Blood Test to Predict Radiation Response & Toxicity in Patients Undergoing

See also
Status	Clinical Trial	Phase
Completed	`NCT04324645` - Active Symptom Monitoring in Patients Undergoing Radiation Therapy for Thoracic Malignancies
Completed	`NCT04776083` - Radiotherapy to the Primary in Metastatic Non-small Cell Lung Cancer Patients	Phase 3
Completed	`NCT01635270` - Phase 2 Study Evaluating Mid-position Strategy in Radiotherapy Treatment for Patients With a Locally Advanced Non-small Cell Lung Carcinoma	Phase 2
Terminated	`NCT03724422` - HO Prophylaxis Therapy for Distal Humerus Fractures	N/A
Recruiting	`NCT03731130` - Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant Radiation or Chemoradiation Followed by Surgery in Patients With Rectal Cancer
Recruiting	`NCT04983095` - Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer	Phase 3
Recruiting	`NCT05721053` - Improving Outcomes for Older Adults Undergoing Radiation Therapy
Active, not recruiting	`NCT04764227` - Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17)	Phase 2
Not yet recruiting	`NCT05821452` - Immunotherapy Plus Chemotherapy vs. Chemoradiotherapy for Thoracic Squamous Esophageal Carcinoma	Phase 2
Recruiting	`NCT05335148` - Study to Evaluate the Safety of Colchicine	Phase 1
Recruiting	`NCT04362306` - Radiation Oncology Patient Medical Physics Intervention Study	N/A
Completed	`NCT01917890` - Radiosensitizing and Radioprotectve Effects of Curcumin in Prostate Cancer	N/A
Not yet recruiting	`NCT05648253` - Hyivy Device in Post-radiation Patients	N/A
Completed	`NCT03235427` - The CAROLE (CArdiac Related Oncologic Late Effects) Study
Recruiting	`NCT05406063` - Stereotactic Multiple Fraction Radiotherapy for Non-spine Bone Metastases	N/A
Recruiting	`NCT03213925` - Neoadjuvant Chemotherapy Followed by Radiotherapy Alone in Patients With Breast Cancer	Phase 2
Recruiting	`NCT03071289` - A Trial Comparing Observation With Radiation on Pelvic Lymphocysts After Radical Hysterectomy of Cervical Cancer	Phase 3
Recruiting	`NCT06128863` - Pembrolizumab in Combination With Eftilagimod Alpha and Radiotherapy in Neoadjuvant Treatment of Patients With Soft Tissue Sarcoma - EFTISARC-NEO Trial	Phase 2
Recruiting	`NCT05351294` - Assessment of Early Radiation Oncology Involvement Alongside Standard Oncologic Care in the Managemet	Phase 3
Recruiting	`NCT05817201` - Toripalimab Plus Radiotherapy for Elderly Esophageal Cancer Patients Treated With Non-chemotherapy Strategy	Phase 2/Phase 3

NCT number	NCT03142425
Study type	Observational
Source	DxTerity Diagnostics
Contact	Andrea Arruda, B.S.
Phone	310-537-7857
Email	aarruda@dxterity.com
Status	Recruiting
Phase
Start date	June 19, 2017
Completion date	December 2019

Blood Test to Predict Radiation Response and Toxicity in Patients Undergoing Radiation Therapy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms